KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Total Non-Current Liabilities (2018 - 2026)

Takeda Pharmaceutical has reported Total Non-Current Liabilities over the past 9 years, most recently at $33.5 billion for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities rose 6.25% year-over-year to $33.5 billion; the TTM value through Mar 2026 reached $33.5 billion, up 6.25%, while the annual FY2026 figure was $34.9 billion, 10.52% up from the prior year.
  • Total Non-Current Liabilities was $33.5 billion for Q1 2026 at Takeda Pharmaceutical, up from $31.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $46.0 billion in Q1 2022 and bottomed at $31.5 billion in Q1 2025.
  • The 5-year median for Total Non-Current Liabilities is $37.3 billion (2024), against an average of $37.4 billion.
  • Year-over-year, Total Non-Current Liabilities decreased 18.29% in 2022 and then grew 6.25% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $46.0 billion in 2022, then decreased by 15.88% to $38.7 billion in 2023, then decreased by 3.76% to $37.3 billion in 2024, then dropped by 15.46% to $31.5 billion in 2025, then rose by 6.25% to $33.5 billion in 2026.
  • The last three reported values for Total Non-Current Liabilities were $33.5 billion (Q1 2026), $31.5 billion (Q1 2025), and $37.3 billion (Q1 2024) per Business Quant data.